Mutational load and mutational patterns in relation to age in head and neck cancer

Oncotarget

Volumn 7, Issue 43, 2016, Pages 69188-69199

  Meucci, Stefano ^a   Keilholz, Ulrich ^a   Tinhofer, Ingeborg ^a   Ebner, Oliva A ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Aging; Genomics; Gerotarget; Head and neck squamous cell carcinoma; Sequencing; Somatic mutations

Indexed keywords

ADULT; AGE; AGE DISTRIBUTION; AGED; ARTICLE; CELL MOTILITY; COHORT ANALYSIS; CONTROLLED STUDY; GENE MAPPING; GENE MUTATION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; MAJOR CLINICAL STUDY; MUTATION ACCUMULATION; MUTATION RATE; MUTATIONAL LOAD; TUMOR INVASION; TUMOR VASCULARIZATION; AGING; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; HEAD AND NECK TUMOR; MIDDLE AGED; MUTATION; PATHOLOGY; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; VERY ELDERLY; YOUNG ADULT;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HEAD AND NECK NEOPLASMS; HUMANS; MIDDLE AGED; MUTATION; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 84994219753     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.11312     Document Type: Article

References (52)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010; 127(12): 2893-2917 doi:10.1002/ijc.25516.
2. Keck MK, Zuo Z, Khattri A, Stricker TP, Brown CD, Imanguli M, Rieke D, Endhardt K, Fang P, Bragelmann J, DeBoer R, El-Dinali M, Aktolga S, et al. Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes. Clin Cancer Res. 2014; 21(4): 870-881. doi:10.1158/1078-0432.CCR-14-2481.
3. Leemans CR, Braakhuis BJM, BrakenhoffRH. The molecular biology of head and neck cancer. Nat Rev Cancer. 2011; 11(1): 9-22. doi:10.1038/nrc2982.
4. Fakhry C, Cohen E. The rise of HPV-positive oropharyngeal cancers in the United States. Cancer Prev Res. 2015; 8(1): 9-11. doi:10.1158/1940-6207.CAPR-14-0425.
5. Field N, Lechner M. Exploring the implications of HPV infection for head and neck cancer. Sex Transm Infect. 2015; 0(0): 2014-2016. doi:10.1136/sextrans-2014-051808.
6. Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, Jiang B, Goodman MT, Sibug-Saber M, Cozen W, Liu L, Lynch CF, Wentzensen N, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011; 29(32): 4294-4301 doi:10.1200/JCO.2011.36.4596.
7. Gugic J, Strojan P. Squamous cell carcinoma of the head and neck in the elderly. Reports Pract Oncol Radiother. 2012; 8: 16-25. doi:10.1016/j.rpor.2012.07.014.
8. El-Mofty SK, Lu DW. Prevalence of human papillomavirus type 16 DNA in squamous cell carcinoma of the palatine tonsil, and not the oral cavity, in young patients: a distinct clinicopathologic and molecular disease entity. Am J Surg Pathol. 2003; 27(11): 1463-1470. doi:10.1097/00000478-200311000-00010.
9. Koch WM, Patel H, Brennan J, Boyle JO, Sidransky D. Squamous cell carcinoma of the head and neck in the elderly. Arch Otolaryngol Head Neck Surg. 1995; 121(3): 262-265. doi:10.1016/j.bjoms.2005.05.011.
10. Ershler WB. Why tumors grow more slowly in old people. J Natl Cancer Inst. 1986; 77(4): 837-839.
11. Mountzios G. Optimal management of the elderly patient with head and neck cancer: Issues regarding surgery, irradiation and chemotherapy. World J Clin Oncol. 2015; 6(1): 7-15. doi:10.5306/wjco.v6.i1.7.
12. Italiano A, Ortholan C, Dassonville O, Poissonnet G, Thariat J, Benezery K, Vallicioni J, Peyrade F, Marcy PY, Bensadoun RJ. Head and neck squamous cell carcinoma in patients aged > or = 80 years: patterns of care and survival. Cancer. 2008; 113(11): 3160-3168. doi:10.1002/cncr.23931.
13. Vanderwalde NA, Fleming M, Weiss J, Chera BS. Treatment of older patients with head and neck cancer: a review. Oncologist. 2013; 18(5): 568-78. doi:10.1634/theoncologist.2012-0427.
14. Westmaas JL, Newton CC, Stevens VL, Flanders WD, Gapstur SM, Jacobs EJ. Does a recent cancer diagnosis predict smoking cessation? An analysis from a large prospective US cohort. J Clin Oncol. 2015; doi:10.1200/JCO.2014.58.3088.
15. Baser S, Shannon VR, Eapen GA, Jimenez CA, Onn A, Lin E, Morice RC. Smoking cessation after diagnosis of lung cancer is associated with a beneficial effect on performance status. CHEST J. 2005; 130(6). doi:10.1378/chest.130.6.1784.
16. Lawrence MS, Sougnez C, Lichtenstein L, Cibulskis K, Lander E, Gabriel SB, Getz G, Ally A, Balasundaram M, Birol I, Bowlby R, Brooks D, Butterfield YSN, et al. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015; 517(7536): 576-582 doi:10.1038/nature14129.
17. Ang K, Harris J, Wheeler R. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010; 363(1): 24-35. doi:10.1056/NEJMoa0912217.
18. Maruyama H, Yasui T, Ishikawa-Fujiwara T, Morii E, Yamamoto Y, Yoshii T, Takenaka Y, Nakahara S, Todo T, Hongyo T, Inohara H. Human papillomavirus and p53 mutations in head and neck squamous cell carcinoma among Japanese population. Cancer Sci. 2014; 105(4): 409-417. doi:10.1111/cas.12369.
19. Milholland B, Auton A, Suh Y, Vijg J. Age-related somatic mutations in the cancer genome. Oncotarget. 2015; 6(28): 24627-35. doi: 10.18632/oncotarget.5685.
20. Stransky N, EgloffAM, Tward AD, Kostic AD, Cibulskis K, Sivachenko A, Kryukov GV, Lawrence MS, Sougnez C, McKenna A, Shefler E, Ramos AH, Stojanov P, et al. The mutational landscape of head and neck squamous cell carcinoma. Science. 2011; 333(6046): 1157-1160. doi:10.1126/science.1208130.
21. Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009; 4(1): 44-57. doi:10.1038/nprot.2008.211.
22. White RA, Malkoski SP, Wang X-J. TGFβ signaling in head and neck squamous cell carcinoma. Oncogene. 2010; 29(40): 5437-5446. doi:10.1038/onc.2010.306.
23. Pircher A, Wellbrock J, Fiedler W, Heidegger I, Gunsilius E, Hilbe W. New antiangiogenic strategies beyond inhibition of vascular endothelial growth factor with special focus on axon guidance molecules. Oncol. 2014; 86(1): 46-52 doi:10.1159/000356871.
24. Kuijper S, Turner CJ, Adams RH. Regulation of angiogenesis by Eph-Ephrin interactions. Trends Cardiovasc Med. 2007; 17(5): 145-151. doi:10.1016/j. tcm.2007.03.003.
25. Chen J, Zhuang G, Frieden L, Debinski W. Eph receptors and Ephrins in cancer. Changes. 2012; 29(6): 997-1003. doi:10.1016/j.biotechadv.2011.08.021.
26. Dodelet VC, Pasquale EB. Eph receptors and Ephrin ligands: embryogenesis to tumorigenesis. Oncogene. 2000; 19(49): 5614-5619. doi:10.1038/sj.onc.1203856.
27. Shao Z, Zhang WF, Chen XM, Shang ZJ. Expression of EphA2 and VEGF in squamous cell carcinoma of the tongue: Correlation with the angiogenesis and clinical outcome. Oral Oncol. 2008; 44(12): 1110-1117. doi:10.1016/j.oraloncology.2008.01.018.
28. Dobrzanski P, Hunter K, Jones-Bolin S, Chang H, Robinson C, Pritchard S, Zhao H, Ruggeri B. Antiangiogenic and antitumor efficacy of EphA2 receptor antagonist. 2004;(14): 910-919. doi: 10.1158/0008-5472.CAN-3430-2
29. Brantley DM, Cheng N, Thompson EJ, Lin Q, Brekken RA, Thorpe PE, Muraoka RS, Cerretti DP, Pozzi A, Jackson D, Lin C, Chen J. Soluble Eph A receptors inhibit tumor angiogenesis and progression in vivo. Oncogene. 2002; 21(46): 7011-7026. doi:10.1038/sj.onc.1205679.
30. Cheng N, Brantley D, Fang W Bin, Liu H, Fanslow W, Cerretti DP, Bussell KN, Reith AD, Jackson D, Chen J. Inhibition of VEGF-dependent multistage carcinogenesis by soluble EphA receptors. Neoplasia. 2003; 5(5): 445-456. doi:10.1016/S1476-5586(03)80047-7.
31. Mosch B, Reissenweber B, Neuber C, Pietzsch J. Eph receptors and Ephrin ligands: Important players in angiogenesis and tumor angiogenesis. J Oncol. 2010; 2010:135285. doi:10.1155/2010/135285.
32. Frantz C, Stewart KM, Weaver VM. The extracellular matrix at a glance. J Cell Sci. 2010; 123(Pt 24): 4195-4200. doi:10.1242/jcs.023820.
33. Sprenger CC, Plymate SR, Reed MJ. Aging-related alterations in the extracellular matrix modulate the microenvironment and influence tumor progression. Changes. 2012; 29(6): 997-1003. doi:10.1016/j. biotechadv.2011.08.021.Secreted.
34. Kosmehl H, Berndt A, Strassburger S, Borsi L, Rousselle P, Mandel U, Hyckel P, Zardi L, Katenkamp D. Distribution of laminin and fibronectin isoforms in oral mucosa and oral squamous cell carcinoma. Br J Cancer. 1999; 81(6): 1071-1079 doi:10.1038/sj.bjc.6690809.
35. Wu RX, Bi CS, Yu Y, Zhang LL, Chen FM. Age-related decline in the matrix contents and functional properties of human periodontal ligament stem cell sheets. Acta Biomater. 2015; doi:10.1016/j.actbio.2015.04.024.
36. Kainulainen T, Autio-Harmainen H, Oikarinen A, Salo S, Tryggvason K, Salo T. Altered distribution and synthesis of laminin-5 (kalinin) in oral lichen planus, epithelial dysplasias and squamous cell carcinomas. Br J Dermatol. 1997; 136(3): 331-336. doi:10.1111/j.1365-2133.1997. tb14938.x.
37. Marinkovich MP. Tumour microenvironment: laminin 332 in squamous-cell carcinoma. Nat Rev Cancer. 2007; 7(5): 370-380. doi:10.1038/nrc2089.
38. Richter P, Umbreit C, Franz M, Berndt A, Grimm S, Uecker A, Böhmer FD, Kosmehl H, Berndt A. EGF/TGFβ1 costimulation of oral squamous cell carcinoma cells causes an epithelial-mesenchymal transition cell phenotype expressing laminin 332. J Oral Pathol Med. 2011; 40(1): 46-54. doi:10.1111/j.1600-0714.2010.00936.x.
39. Kinoshita T, Nohata N, Hanazawa T, Kikkawa N, Yamamoto N, Yoshino H, Itesako T, Enokida H, Nakagawa M, Okamoto Y, Seki N. Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin-integrin signalling in head and neck squamous cell carcinoma. Br J Cancer. 2013; 109(10): 2636-45. doi:10.1038/bjc.2013.607.
40. Hunt S, Jones AV, Hinsley EE, Whawell SA, Lambert DW. MicroRNA-124 suppresses oral squamous cell carcinoma motility by targeting ITGB1. FEBS Lett. 2011; 585(1): 187-192. doi:10.1016/j.febslet.2010.11.038.
41. Foubert P, Varner JA. Integrins in tumor angiogenesis and lymphangiogenesis. Methods Mol Biol. 2011; 757: 471-486 doi:10.1007/978-1-61779-166-6_27.
42. Fransvea E, Mazzocca A, Antonaci S, Giannelli G. Targeting transforming growth factor (TGF)-betaRI inhibits activation of beta1 integrin and blocks vascular invasion in hepatocellular carcinoma. Hepatology. 2009; 49(3): 839-850 doi:10.1002/hep.22731.
43. Desgrosellier JS, Cheresh DA. Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer. 2010; 10(1): 9-22. doi:10.1038/nrc2965.
44. Golubovskaya VM, Kweh F, Cance WG. Focal adhesion kinase and cancer. Histol Histopathol. 2008; 24(4):503-10.
45. Canel M, Secades P, Garzón-Arango M, Allonca E, Suarez C, Serrels A, Frame M, Brunton V, Chiara M-D. Involvement of focal adhesion kinase in cellular invasion of head and neck squamous cell carcinomas via regulation of MMP-2 expression. Br J Cancer. 2008; 98(7): 1274-1284. doi:10.1038/sj.bjc.6604286.
46. Bray SJ. Notch signalling: a simple pathway becomes complex. Nat Rev Mol Cell Biol. 2006; 7(9): 678-689. doi:10.1038/nrm2009.
47. Zhang H, Wang X, Xu J, Sun Y. Notch1 activation is a poor prognostic factor in patients with gastric cancer. Br J Cancer. 2014; 110(9): 2283-90. doi:10.1038/bjc.2014.135.
48. Ranganathan P, Weaver KL, Capobianco AJ. Notch signalling in solid tumours: a little bit of everything but not all the time. Nat Rev Cancer. 2011; 11(5): 338-351. doi:10.1038/nrc3035.
49. Yap L, Lee D, Khairuddin A, Pairan M, Puspita B, Siar C, Paterson I. The opposing roles of NOTCH signalling in head and neck cancer: a mini review. Oral Dis. 2015; 21(7): 850-7. doi:10.1111/odi.12309.
50. Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E, Cerami E, Sander C, Schultz N, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013; 6(269): pl1. doi:10.1126/scisignal.2004088.
51. Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, Antipin Y, Reva B, Goldberg AP, et al. The cBio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012; 2(5): 401-4. doi:10.1158/2159-8290.CD-12-0095.
52. R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing; 2014.